FreeGuest Editorial Goodman: Too Many PD-1 Trials for Adults, Too Few for Children October 14, 2016Vol.42 No.38By Nancy Goodman
Conversation with The Cancer LetterFree Perspectives on Clinical Development of PD-1 Drugs October 07, 2016Vol.42 No.37
Free With 20 Agents, 803 Trials, and 166,736 Patient Slots, Is Pharma Investing Too Heavily in PD-1 Drug Development? October 07, 2016Vol.42 No.37By Laura Brawley
Free NCI Suspends Frederick Lab Re-Competition Citing Moonshot, Zika and Ebola Research September 30, 2016Vol.42 No.36By Paul Goldberg
Free Continuing Resolution Funds Zika, But Not Cancer or Biden’s Moonshot September 30, 2016Vol.42 No.36
Conversation with The Cancer Letter NCI’s Care Delivery Research Program Seeks to Involve Scientists from Other Fields September 30, 2016Vol.42 No.36By Paul Goldberg
Free Two Gigantic Health Systems Integrate Cancer Data to Bring Precision Medicine to Community Care September 30, 2016Vol.42 No.36By Matthew Bin Han Ong
Conversation with The Cancer Letter OHSU Seeks to Raise another $1 Billion; Keith Todd Describes the Strategy September 23, 2016Vol.42 No.35By Paul Goldberg
Free No Moonshot Funds In House & Senate FY17 Appropriations Bills September 23, 2016Vol.42 No.35By Matthew Bin Han Ong
